Italy, Milan 
Dr. Dario Trapani is a medical oncologist and internationally recognized expert in breast cancer, precision oncology, and global cancer policy. His work bridges clinical research, drug development, and health systems innovation, with a strong focus on improving access to cancer care and advancing value-based oncology worldwide. He is actively involved in shaping international oncology policy and guidelines through leadership roles in major global organizations.
Current Position
- Assistant Professor of Medical Oncology, University of Milan
- Attending Physician, Division of Early Drug Development, European Institute of Oncology (IEO)
- Chair, Cancer Medicines Committee, European Society for Medical Oncology (ESMO)
- Advisor and Working Group Member, World Health Organization
Education
- MD, University of Salerno
- Residency in Medical Oncology, University of Milan
- Advanced Clinical-Research Fellowship in Breast Cancer, Dana-Farber Cancer Institute
Areas of Specialization
- Breast cancer (early-stage and metastatic)
- Precision oncology and biomarker-driven treatment strategies
- Early-phase clinical trials (Phase I–III)
- Oncology drug development and therapeutic sequencing
- Global oncology and cancer care delivery systems
- Health technology assessment (HTA) and value-based oncology
- Access to cancer medicines and health equity
- Cancer policy, guideline development, and priority-setting frameworks
Clinical & Research Focus
- Optimization of treatment strategies in breast cancer
- Development and evaluation of targeted therapies and antibody-drug conjugates
- Biomarker integration in clinical decision-making (e.g., genomic signatures, ctDNA)
- De-escalation strategies and personalized treatment approaches
- Clinical trial design, methodology, and interpretation
- Economic evaluation and sustainability of oncology treatments
Academic Profile
- Author of an extensive body of peer-reviewed publications in leading journals including The Lancet Oncology, JAMA Oncology, and European Journal of Cancer
- Section Editor, ESMO Open (cancer policy, global oncology)
- Section Editor, Journal of Cancer Policy
- Editorial Board Member, Cancer Treatment Reviews, The Oncologist, The Lancet Oncology
- Reviewer for high-impact journals including Nature Medicine, JCO, BMJ, and others
Innovation & Policy Contribution
- Leading advocate for sustainable and equitable cancer care delivery
- Contributor to WHO frameworks on essential cancer medicines and diagnostics
- Developer of methodologies integrating clinical benefit, affordability, and policy decision-making
- Active in shaping global standards for oncology drug evaluation and reimbursement
Professional Memberships
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Italian Association of Medical Oncology (AIOM)
- European School of Oncology (ESO)
Honors & Distinctions
- Dana-Farber Advanced Fellowship in Breast Oncology
- European Institute of Oncology Merit Award for Young Oncologists
- Multiple competitive research grants and international recognitions